key: cord-0807372-dr7rtdm4
authors: Kunstler, Breanne; Newton, Skye; Hill, Hayley; Ferguson, John; Hore, Phillipa; Mitchell, Brett G.; Dempsey, Kathy; Stewardson, Andrew J.; Friedman, Deborah; Cole, Kate; Sim, Malcolm R.; Ferguson, Bridget; Burns, Penelope; King, Nicole; McGloughlin, Steven; Dicks, Melanie; McCarthy, Sally; Tam, Barry; Hazelton, Briony; McGurgan, Cherylynn; McDonald, Steve; Turner, Tari
title: P2/N95 respirators & surgical masks to prevent SARS-CoV-2 infection: Effectiveness & adverse effects
date: 2022-01-20
journal: Infect Dis Health
DOI: 10.1016/j.idh.2022.01.001
sha: 8d58203d6d5a4ae8b8259284f6b4373bbed51ab2
doc_id: 807372
cord_uid: dr7rtdm4

BACKGROUND: Millions of people have acquired and died from SARS-CoV-2 infection during the COVID-19 pandemic. Healthcare workers (HCWs) are required to wear personal protective equipment (PPE), including surgical masks and P2/N95 respirators, to prevent infection while treating patients. However, the comparative effectiveness of respirators and masks in preventing SARS-CoV-2 infection and the likelihood of experiencing adverse events (AEs) with wear are unclear. METHODS: Searches were carried out in PubMed, Europe PMC and the Cochrane COVID-19 Study Register to 14 June 2021. A systematic review of comparative epidemiological studies examining SARS-CoV-2 infection or AE incidence in HCWs wearing P2/N95 (or equivalent) respirators and surgical masks was performed. Article screening, risk of bias assessment and data extraction were duplicated. Meta-analysis of extracted data was carried out in RevMan. RESULTS: Twenty-one studies were included, with most having high risk of bias. There was no statistically significant difference in respirator or surgical mask effectiveness in preventing SARS-CoV-2 infection (OR 0.85, [95%CI 0.72, 1.01]). Healthcare workers experienced significantly more headaches (OR 2.62, [95%CI 1.18, 5.81]), respiratory distress (OR 4.21, [95%CI 1.46, 12.13]), facial irritation (OR 1.80, [95%CI 1.03, 3.14]) and pressure-related injuries (OR 4.39, [95%CI 2.37, 8.15]) when wearing respirators compared to surgical masks. CONCLUSION: The existing epidemiological evidence does not enable definitive assessment of the effectiveness of respirators compared to surgical masks in preventing infection. Healthcare workers wearing respirators may be more likely to experience AEs. Effective mitigation strategies are important to ensure the uptake and correct use of respirators by HCWs.

Coronavirus disease (COVID-19) is a serious acute respiratory syndrome caused by the coronavirus SARS-CoV-2, which was declared a worldwide pandemic in March 2020 (1). The virus can be transmitted from an infected person's mouth or nose in the form of respiratory particles which can then infect others through contamination of their eyes, nose or mouth (2, 3) .

In healthcare settings, personal protective equipment (PPE) respiratory protection usually includes a surgical mask or P2/N95 respirator. PPE is considered only one method of preventing SARS-CoV-2 transmission and it is recommended that it be used within a suite of control measures (4, 5) . Prevention of virus transmission needs to be based on the hierarchy of controls, such as isolation, effective ventilation, and administrative controls such as physical distancing, surveillance testing, hand hygiene, vaccination and the use of PPE (5). Application of PPE also needs to be balanced with patient care and interaction risk assessment to match appropriate application of PPE (6).

A surgical mask is made of disposable material that ties around the back of the head and is designed for use in procedures that do not require respiratory protection from the airborne transmission pathway (7) . Particulate respirators, such as P2/N95 or equivalent (e.g. FFP2, KN95 and KF94 respirators) herein referred to as "respirators", are designed to protect the wearer from the inhalation of respiratory particles. Unlike surgical masks, respirators are required to meet a standard to reduce exposure of the wearer by at least 95% of particles in the wearer's breathing zone. It has been reported that respirators protect the wearer from 96% of coronavirus transmission, compared to surgical masks that offer 67% protection (8) .

Respirators have historically been preferred in the healthcare setting when the risk of pathogen transmission via respiratory particles (e.g. respiratory viruses) is considered likely (9) .

To date, insufficient high-quality epidemiological evidence exists to support healthcare workers (HCWs) using P2/N95 respirators instead of surgical masks to prevent SARS-CoV-2 infection (10) . A previous meta-analysis examining the effectiveness of respirators compared to surgical masks in preventing infection of HCWs by respiratory viruses (e.g. influenza, adenovirus, echoviruses and coronaviruses) found no significant difference between surgical masks and respirators (11) , with these findings further supported by a recent network metaanalysis (12). Inconsistencies related to the understanding of the effectiveness of surgical masks and respirators for preventing SARS-CoV-2 infection among HCWs in different clinical contexts (e.g. when performing perceived high risk procedures compared to not) have contributed to the production of respiratory protection guidelines over the course of the COVID-19 pandemic that have different recommendations (13) .

HCWs are at the forefront of SARS-CoV-2 infection management. They are exposed to symptomatic and asymptomatic people who might be infected with SARS-CoV-2, making them susceptible to infection themselves (14) . Due to the uncertainty surrounding the infection status of individual people, HCWs have been required in guidelines, health and safety legislation and by workplace management to wear PPE, such as surgical masks and respirators, as one means to prevent infection (15) . However, mandating mask and respirator use might not lead to use, suggesting that barriers to use are important considerations when mandating specific PPE (16). During the pandemic, HCWs have needed to wear PPE for several hours and days in a row, rendering them susceptible to adverse events (AEs) associated with prolonged contact between mask material and the skin (17) (18) (19) , such as injury and absenteeism (20) , prompting measures to be taken to protect the skin of HCWs wearing PPE (21) .

The aim of this systematic review and meta-analysis was to examine the differences in likelihood of SARS-CoV-2 infection and AEs between HCWs using respirators and surgical masks. The findings of this review were referenced in the development of practice recommendations guiding PPE choice by Australian HCWs (6).

The selection criteria were determined a priori and approved by the (detail removed as it contains author information).

A Population, Intervention, Comparator and Outcome (PICO) framework was used to frame the following inclusion criteria:

• Population: HCWs (e.g. doctors, nurses, allied health professionals and support workers) working in settings involving contact with individuals diagnosed or potentially infected with SARS-CoV-2, such as primary care, tertiary care, residential care, patient transport and managed quarantine • Intervention: FFP2, N95, KN95, KF94, P2 or equivalent respirators • Comparator: surgical masks • Outcomes: SARS-CoV-2 infection or AEs (e.g. signs and symptoms of skin conditions) • Study design: all pre-print or peer-reviewed comparative epidemiological studies. No date limits were applied. Only studies published in English that directly compared infection and AE outcomes of respirator or surgical mask were included.

The rapid living systematic review on the effectiveness of PPE in preventing SARS-CoV-2 infection in HCWs by Chou, Dana (10) was used to identify relevant effectiveness studies published before December 2020. PubMed and the Cochrane COVID-19 Study Register (to ensure planned studies were identified and monitored for published results) were frequently searched to identify emerging data on infection incidence from December 2020 to 14 June 2021 using a search strategy adapted from Chou et al., 2020. These databases, and Europe PMC (restricted to preprints), were also searched on 14 June 2021, but without date restrictions, using terms specific to AEs (Supplementary material). During the same period, Research Square and medRxiv were screened daily for preprints, and the New South Wales Health COVID-19 Critical Intelligence Unit Daily Evidence Digest was scanned daily for additional sources of information (such as guidance documents).

Potentially eligible citations were imported into Covidence, an online systematic review tool, for screening. Full-text screening was performed in duplicate, with reasons for exclusion documented. Conflicts were resolved by consensus or third reviewer.

Data were extracted in duplicate with conflicts resolved by consensus or third reviewer. Review Manager (RevMan 5.4) was used to pool results using the Mantel-Haenszel method and random effects model to calculate odds ratios and 95% confidence intervals (95%CI). Data on AEs and infection were extracted as event counts where possible, allowing the calculation of odds ratios. Erythema data were pooled to form standardised mean differences (SMD) and standard deviations (SD) using a random effects model.

Two researchers independently assessed the risk of bias using either the ROBINS-I tool for non-randomised studies or the RoB-2 tool for randomised studies (22, 23) . Differences were resolved by consensus.

After removing duplicates, 2,646 records were screened. The full texts of 268 were screened for eligibility, from which 21 studies met the inclusion criteria (Fig 1) .

Most studies were observational, with only one being an RCT, and included adults with a mean age between 29 and 46 years. Most had a majority female representation (ranging from 39% in Niikura, Fujishiro (24) to 90% in Han, Shin (25) ). Most studies compared HCWs wearing surgical masks or N95 respirators (n=16), and the remaining studies compared HCWs wearing surgical masks compared to KF94 or KF95 (n=1), FFP2 (n=3) or various respirator types (n=1). Studies were conducted in several different countries (although the USA was the most represented [n=8]) and ranged widely in participant number (e.g. 20 participants in Han, Shin (25) compared to 20,614 in Sims, Maine (26)) ( Table 1) .

The majority of the studies were at high risk of bias (n=18/21) (16, 24, 26-41) primarily due to the potential for recall bias (e.g. use of self-report surveys), participation bias (e.g. potential for only those with specific interest to participate) and small participant numbers. Further, adjustment for several confounding variables that might impact the likelihood of acquiring SARS-CoV-2 or AEs was lacking. Descriptions of SARS-CoV-2 activity in the community and the predominant variant (where greater activity in the community suggests greater infection risk (29)), vaccination status of HCWs, clinical tasks performed by HCWs, use of respirator fit-testing and checking, type and use of additional PPE, comorbidities expected to exacerbate potential AEs (e.g. smoking and allergies (34) ), duration of wear and mitigation strategies used to reduce AE incidence or severity were inconsistently reported. Furthermore, the use of PPE outside of the healthcare setting was rarely discussed, J o u r n a l P r e -p r o o f potentially leading to inaccuracies in infection and AE counts assumed to result from exposure to SARS-CoV-2 in the healthcare setting alone. The infection and AE count, and consequently our summarised findings, might be influenced positively or negatively by any or all of these variables.

Twelve studies reported the rate of SARS-CoV-2 infection in HCWs who wore surgical masks compared to those who wore respirators (16, 24, 26-29, 31, 33, 35, 37, 38, 40) . Overall, a similar percentage of HCWs wearing respirators (1,398/15,598 = 8.96%) and surgical masks (1,698/17,947 = 9.46%) acquired SARS-CoV-2 infection (Fig 2) . The likelihood of HCWs becoming infected with SARS-CoV-2 did not significantly differ between HCWs wearing respirators compared to those wearing surgical masks (OR 0.85, [95%CI 0.72, 1.01], I 2 = 60%) (Fig 2) .

Eight studies contributed data to the meta-analyses of AEs (25, 30, 32, 34, 36, 39, 41, 42) , with findings from Zuo, Hua (43) 10 .87], I 2 = 77%))(32, 34) did not differ significantly between the groups (Fig 3) . Likewise, degree of erythema did not significantly differ between groups (SMD -0.29, [95%CI -0.82, 0.25], I 2 = 0%) (25, 36) .

This systematic review and meta-analysis of epidemiological studies aimed to compare the likelihood of HCWs acquiring SARS-CoV-2 infection and experiencing AEs when wearing surgical masks or respirators at work. Twenty-one studies contributed to the overall analysis, the majority of which had a high risk of bias, limiting our ability to provide definitive results. Results of meta-analyses did not find a statistically significant difference in the likelihood of J o u r n a l P r e -p r o o f HCWs wearing surgical masks or respirators becoming infected with SARS-CoV-2. However, HCWs wearing respirators had a higher likelihood of experiencing de novo headache, respiratory distress or shortness of breath, facial itching or irritation, and pressure-related injuries compared to those wearing surgical masks.

It should not be assumed that respirators do not provide superior protection from infection based on these results. Although the likelihood of infection was not significantly different between HCWs wearing surgical masks compared to respirators, the direction of effect favoured the use of respirators and the risk of bias of included studies was high, with many important confounders not adjusted for. For example, HCWs might be more likely to wear respirators when they work in high infection-risk situations, such as in intensive care units (ICU), or when performing aerosol-generating procedures. The use of various respirators during aerosol-generating procedures has been shown to reduce infection risk (44) . Thus, clinical context could influence infection risk and not adjusting for this could potentially bias infection outcomes towards the null. Therefore, the inability of this review to demonstrate a statistically significant difference in the effect of respirators and surgical masks in protecting against infection might suggest that current risk-stratification approaches, where those working in higher risk settings wear respirators, may effectively reduce SARS-CoV-2 transmission.

Without randomised trials with large participant numbers that control for relevant confounding factors (e.g. use of additional infection control measures), the conclusions regarding the comparison between respirators and surgical masks remain tentative, and guidelines specific to PPE use might remain inconsistent (13) . The ethics of deliberately exposing HCWs to SARS-CoV-2 in settings where safety may be compromised (e.g. ICU) remain questionable. Thus, studies that control for potential confounding variables are unlikely to be conducted. Consequently, it remains important to use existing infection prevention and control guidelines to guide the appropriate clinical use of respirators and surgical masks (5).

HCWs wearing respirators instead of surgical masks experience more AEs, potentially reducing their willingness to use them, or use them correctly (i.e. avoiding touching them). For example, itching can encourage the wearer to adjust a respirator, potentially putting them at a greater risk for infection by compromising the seal (43) . It has been suggested that the humidity from exhaled breath and sweat accumulation underneath a respirator, as well as the prevention of dry air entering the sealed space, could create pressure and moisturerelated discomfort and skin damage (30, 42, 45) . In addition, a relationship might exist between hypercapnia and wearing of respirators, possibly contributing to headaches and shortness of breath in wearers (46) . Thus, seeing greater odds of HCWs wearing respirators experiencing pressure sores, facial itching or irritation, headaches and shortness of breath or respiratory distress is unsurprising. These effects might also be exacerbated the longer the mask is worn for (19, 47) . Although these findings are supported by similar recently published literature (48) , the small number of studies, wide confidence intervals, small sample sizes and the substantial potential for confounding (i.e. lack of controlling for stress and air ventilation (34, 39) ) suggests that caution should be taken when using these findings to inform decision making regarding PPE choice. The presence of AEs should not encourage HCWs to avoid respirator use, but instead encourage them to use appropriate mitigation strategies to ensure comfort and safety.

The Australian guidelines for SARS-CoV-2 infection prevention and control of COVID-19 in HCWs recommend that Australian HCWs have access to and use fit-tested and, at time of use, fit-checked respirators when there is a high risk of SARS-CoV-2 transmission to the HCW (6). It is important to mitigate any AEs HCWs might experience when choosing to use a respirator to support effective use. Mitigation strategies used by HCWs include medical assessments to identify pre-existing skin or respiratory problems, early medical assessment should any AEs develop, fit-testing by a person competent in identifying the best-fitting respirator for the HCW, use of well-designed respirators (e.g. those that fit the face well, preventing the need to excessively tighten straps), taking breaks from respirator wearing or interchanging between mask types as appropriate (i.e., avoiding universal use), working shorter shifts, and using topical creams and washes to prevent and treat skin complaints (32, 34, 39, 41, 42, 47, (49) (50) (51) . The use of hydrogel patches and similar dressings can also reduce the prevalence and subjective experience of skin injuries (52) . However, it is important to ensure respirators still pass fit-testing once mitigation strategies have been implemented to ensure ongoing effectiveness. Organisations should consider how to most effectively manage and mitigate AEs from respirator and surgical mask use in the context of a wider respiratory protection program.

It is difficult to draw definitive conclusions on infection and AE likelihood from the epidemiological studies included in this review given the high risk of bias. Most studies included in this review had small sample sizes and could be potentially impacted by important confounders, such as whether respirators were fit-tested and fit-checked prior to use. This is important because the effectiveness of respirators depends on appropriate fit (4) . Future research should be designed to control or adjust for variables, such as the use of fit-checked and fit-tested respirators, SARS-CoV-2 prevalence and variant in the community, and the presence of relevant contextual factors that might impact infection and AE risk (e.g. levels of ventilation, mask-wearing duration or closer/longer duration contact with infected patients). This review should be updated once more high quality, peer-reviewed epidemiological studies are published.

This review has some limitations worthy of consideration. Although our search covered PubMed and the Cochrane COVID-19 Study Register (including relevant studies from Embase, medRxiv and ClinicalTrials.gov), we did not search CINAHL and so cannot rule out the possibility that some studies may have been overlooked. Some of the included studies were published as preprints and have not been peer-reviewed prior to inclusion. However, all studies were subject to risk of bias assessment. The studies exploring infection rate used different outcome measures (i.e. polymerase chain reaction test vs. serology). It is unclear how the use of different tests might have affected infection counts. Importantly, given the lack of controlled studies in this area, the findings of this review cannot imply causation but rather suggest the presence of a relationship between the use of surgical masks or respirators and infection rate and AEs, the nature of which requires further exploration.

This review has several strengths. This review reports findings specific to infection rates in HCWs wearing surgical masks and respirators, but also the likelihood of HCWs experiencing AEs from such devices. Thus, the findings of this review, and practical suggestions for mitigating AEs, have useful clinical applications. The methods underpinning this review have been extensively applied in various research and policy settings (53) , ensuring rigorous evidence identification and synthesis to inform the development of clinically relevant and J o u r n a l P r e -p r o o f informed recommendations for practice. The formulation of the research question and discussion around applicability to practice and practical suggestions to support uptake of respirator use was made possible by collaboration with a multidisciplinary group with wideranging expertise in clinical care, occupational hygiene, medicine and engineering.

HCWs treating patients infected with SARS-CoV-2 are required to wear appropriate PPE, in addition to other control measures, to minimise infection risk. The existing epidemiological evidence is at high risk of bias and does not enable a definitive assessment of the effectiveness of respirators compared to surgical masks in preventing infection. Healthcare workers wearing respirators may be more likely to experience de novo headaches, shortness of breath or respiratory distress, facial itching or irritation, and pressure sores compared to those wearing surgical masks. These AEs require effective mitigation strategies to facilitate the uptake and correct use of respirators by HCWs who are required to use them. Our findings should not be used to justify decisions for or against respirator use.

Ethics approval and informed consent was not required as this was a systematic review of previously published data.

In More erythema was experienced in skin areas covered by respirators compared to surgical masks, albeit not statistically significant. Furthermore, there were no significant differences in skin hydration, sebum secretion, and pH between surgical mask and respirator groups.

70% of surgical mask users wore them for >8 hours, compared to 60% of respirator users. There was no statistically significant difference in mask wear time between the groups.

Ipek The use of N95 respirators and goggles was associated with significantly more skin injuries (device-related pressure injuries, moisture-associated skin damage and skin tears) than surgical masks and goggles (89.5% vs 37.4%, P < .001). HCWs who used enhanced respiratory protection (surgical mask or respirators) during exposure to SARS-CoV-2 in the healthcare setting had more asymptomatic disease than those who acquired the disease in the community, where they experienced more symptomatic disease. There was no statistically significant difference in the number of HCWs using respirators or surgical masks testing positive for SARS-CoV-2. HCWs frequently exposed to COVID-19 were less likely to test positive for SARS-CoV-2 when using respirators compared to surgical masks (aOR 0.06, p=0.035). Universal use of respirators when AGPs showed no statistically significant reduction in likelihood of testing positive for SARS-CoV-2.

HCWs wearing respirators more often reported wearing masks outside of work (35% v 26%), being involved in AGPs (64% v 29%), working in ICU (26% v 4%) and having contact with >20 patients with COVID-19 (58% v 32%). Data extraction and synthesis 13e Describe any methods used to explore possible causes of heterogeneity among study results (e.g. subgroup analysis, metaregression).

-13f Describe any sensitivity analyses conducted to assess robustness of the synthesized results. -

14 Describe any methods used to assess risk of bias due to missing results in a synthesis (arising from reporting biases). Funnel plot performed (but not described due to word count. Detail available on request)

Certainty assessment 15 Describe any methods used to assess certainty (or confidence) in the body of evidence for an outcome. GRADE was used, but not described (due to word count. Detail available on request)

16a Describe the results of the search and selection process, from the number of records identified in the search to the number of studies included in the review, ideally using a flow diagram.

16b Cite studies that might appear to meet the inclusion criteria, but which were excluded, and explain why they were excluded. PRISMA flowchart for number of studies excluded with reasons. Authors can be contacted for full list of citations.

Study characteristics 17 Cite each included study and present its characteristics. Table 1 Risk of bias in studies 18 Present assessments of risk of bias for each included study. Table 1 Results of individual studies 19 For all outcomes, present, for each study: (a) summary statistics for each group (where appropriate) and (b) an effect estimate and its precision (e.g. confidence/credible interval), ideally using structured tables or plots. 23c Discuss any limitations of the review processes used. Discussion paragraph 7

23d Discuss implications of the results for practice, policy, and future research. Conclusion

Registration and protocol 24a Provide registration information for the review, including register name and registration number, or state that the review was not registered.

Protocol was not registered (statement removed due to word count) but selection criteria were signed off a priori (under 'protocol') 24b Indicate where the review protocol can be accessed, or state that a protocol was not prepared. NA 24c Describe and explain any amendments to information provided at registration or in the protocol. No amendments Support 25 Describe sources of financial or non-financial support for the review, and the role of the funders or sponsors in the review. Funding

26 Declare any competing interests of review authors.

Availability of data, code and other materials 27 Report which of the following are publicly available and where they can be found: template data collection forms; data extracted from included studies; data used for all analyses; analytic code; any other materials used in the review.

NA

WHO Declares COVID-19 a Pandemic

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

Aerodynamic Analysis of SARS-CoV-2 in Two Wuhan Hospitals

5. National Health and Medical Research Council. Australian Guidelines for the Prevention and Control of Infection in Healthcare Canberra

National COVID-19 Clinical Evidence Taskforce. Australian Guidelines for SARS-CoV-2 Infection Prevention and Control of COVID-19 in Healthcare Workers

Single-Use Face Masks for Use in Health Care

Face Masks, and Eye Protection to Prevent Person-to-Person Transmission of SARS-CoV-2 and COVID-19: A Systematic Review and Meta-Analysis

World Health Organization. Infection Prevention and Control of Epidemic-and Pandemic-Prone Acute Respiratory Infections in Health Care: World Health Organization

Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings : A Living Rapid Review

Medical Masks Vs N95 Respirators for Preventing COVID-19 in Healthcare Workers: A Systematic Review and Meta-Analysis of Randomized Trials. Influenza Other Respir Viruses

Protective Efficient Comparisons among All Kinds of Respirators and Masks for Health-Care Workers against Respiratory Viruses: A PRISMA-Compliant Network Meta-Analysis

Variation of National and International Guidelines on Respiratory Protection for Health Care Professionals During the COVID-19 Pandemic

Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan

Effectiveness of Masks and Respirators against Respiratory Infections in Healthcare Workers: A Systematic Review and Meta-Analysis

Update to Device-Related Pressure Ulcers: Secure Prevention. COVID-19, Face Masks and Skin Damage

Influence of Polyester Spacer Fabric, Cotton, Chloroprene Rubber, and Silicone on Microclimatic and Morphologic Physiologic Skin Parameters in Vivo

The Association of the Prolonged Use of Personal Protective Equipment and Face Mask During COVID-19 Pandemic with Various Dermatologic Disease Manifestations: A Systematic Review

Personal Protective Equipment Induced Facial Dermatoses in Healthcare Workers Managing Coronavirus Disease

Novel Coronavirus Disease Epidemic: Skin Protection for Healthcare Workers Must Not Be Ignored

ROBINS-I: A Tool for Assessing Risk of Bias in Non-Randomised Studies of Interventions

RoB 2: A Revised Tool for Assessing Risk of Bias in Randomised Trials

Assessing Coronavirus Disease 2019 (COVID-19) Transmission to Healthcare Personnel: The Global ACT-HCP Case-Control Study

Facial Skin Temperature and Discomfort When Wearing Protective Face Masks: Thermal Infrared Imaging Evaluation and Hands Moving the Mask

Face-Mask Amongst Healthcare Providers

Personal Protective Equipment-Related Occupational Dermatoses During COVID-19 among Health Care Workers: A Worldwide Systematic Review

Impact of Personal Protective Equipment Use on Health Care Workers' Physical Health During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis

Health Care Workers' Views About Respirator Use and Features That Should Be Included in the Next Generation of Respirators

Department of Health and Human Services. Victorian Respiratory Protection Program Guidelines

Skin Adverse Events Related to Personal Protective Equipment: A Systematic Review and Meta-Analysis

Breathing Life into Australian Diabetes Clinical Guidelines

International Observational Survey of the Effectiveness of Personal Protective Equipment During Endoscopic Procedures Performed in Patients with COVID-19

Coronavirus Disease 2019 (COVID-19) Seropositivity and Asymptomatic Rates in Healthcare Workers Are Associated with Job Function and Masking

Seroprevalence among Healthcare, First Response, and Public Safety Personnel

Seroepidemiology among Employees of New York City Health and Hospitals During the First Wave of the SARS-CoV-2 Epidemic

Healthcare-Acquired Coronavirus Disease 2019 (COVID-19) Is Less Symptomatic Than Community-Acquired Disease among Healthcare Workers

Use of Respirator Vs. Surgical Masks in Healthcare Personnel and Its Impact on SARS-CoV-2 Acquisition: A Prospective Multicentre Cohort Study

A SARS-CoV-2 Cluster in an Acute Care Hospital

Severe Acute Respiratory Coronavirus Virus 2 (SARS-CoV-2) Seroconversion and Occupational Exposure of Employees at a Swiss University Hospital: A Large Longitudinal Cohort Study

COVID-19 and the Risk to Health Care Workers: A Case Report

Aerosolized SARS-CoV-2 Transmission Risk: Surgical or N95 Masks?

SARS-CoV-2 Seroprevalence among Health Care Workers in a New York City Hospital: A Cross-Sectional Analysis During the COVID-19 Pandemic

Included AE studies

Changes in Skin Characteristics after Using Respiratory Protective Equipment (Medical Masks and Respirators) in the COVID-19 Pandemic among Healthcare Workers

Physiologic Effects and Symptoms Associated with Extended-Use Medical Mask and N95 Respirators

Is N95 Face Mask Linked to Dizziness and Headache? Int Arch Occup Environ Health

Comfort Rules for Face Masks among Healthcare Workers During COVID-19 Spread

Impact of Gloves and Mask Use on Epidermal Barrier Function in Health Care Workers

Mask-Associated 'De Novo' Headache in Healthcare Workers During the COVID-19 Pandemic

Cutaneous Impact of Surgical Mask Versus N95 Mask During COVID-19 Pandemic: Incidence of Dermatological Side Effects and Response of Topical Methylprednisolone Aceponate (MPA) Treatment to Associated Contact Dermatitis

Association between Skin Injuries in Medical Staff and Protective Masks Combined with Goggles During the COVID-19 Pandemic

AND (Health Personnel[Mesh] OR clinician OR clinicians OR doctor OR doctors OR physician OR physician OR nurse OR nurses OR midwife OR midwives OR ambulance OR "first responder" OR "first responders" OR EMT OR EMTs OR HCWs OR ((health OR healthcare OR "health care" OR clinic* OR medical OR laboratory) AND (work OR worker* OR personnel OR practitioner* OR staff OR employee* OR professional*))) AND (SARS-CoV-2

TITLE:"mask") OR (TITLE:"masks") OR (TITLE:"respirator") OR (TITLE:"respirators") OR (TITLE:"respiratory protective equipment") OR (TITLE:"N 95") OR (TITLE:"N95") OR (TITLE:"KN95") OR (TITLE:"FFP") OR (TITLE:"FFP2") OR (TITLE:"facepiece") OR (TITLE:"facepieces") OR (TITLE:"facemask") OR (TITLE:"facemasks")) AND ((TITLE:"adverse") OR (TITLE:"reaction") OR (TITLE:"reactions") OR (ABSTRACT:"adverse") OR

HCWs performing AGPs were exposed to the patient for approximately 34min (mean).Mean mask wearing time not reported.

For studies published before December 2020, we screened studies included in the rapid living systematic review of the effectiveness of PPE for preventing SARS-CoV-2 infection in HCWs (Chou et al., 2020) . 

Selection process 8 Specify the methods used to decide whether a study met the inclusion criteria of the review, including how many reviewers screened each record and each report retrieved, whether they worked independently, and if applicable, details of automation tools used in the process.

Data collection process 9 Specify the methods used to collect data from reports, including how many reviewers collected data from each report, whether they worked independently, any processes for obtaining or confirming data from study investigators, and if applicable, details of automation tools used in the process.

Data items 10a List and define all outcomes for which data were sought. Specify whether all results that were compatible with each outcome domain in each study were sought (e.g. for all measures, time points, analyses), and if not, the methods used to decide which results to collect.

10b List and define all other variables for which data were sought (e.g. participant and intervention characteristics, funding sources).Describe any assumptions made about any missing or unclear information.

Study risk of bias assessment 11 Specify the methods used to assess risk of bias in the included studies, including details of the tool(s) used, how many reviewers assessed each study and whether they worked independently, and if applicable, details of automation tools used in the process.

Effect measures 12 Specify for each outcome the effect measure(s) (e.g. risk ratio, mean difference) used in the synthesis or presentation of results. Data extraction and synthesis Synthesis methods 13a Describe the processes used to decide which studies were eligible for each synthesis (e.g. tabulating the study intervention characteristics and comparing against the planned groups for each synthesis (item #5)).

Authorship statement TT, SN, HH and BK (as internal team members of The National COVID-19 Clinical Evidence Taskforce) collaborated with and the remaining authors (the IPC Panel members) to conceive the review and draft the guiding research questions. A search specialist, SM, conducted all database searches. SN, HH and BK screened search yields, extracted data from included studies and performed statistical analyses. All authors contributed to interpretation of the analysis. BK, SN, TT and HH wrote the manuscript. All authors provided critical review and approved the final manuscript.